Minimal Functional Structure of Escherichia coli 4.5 S RNA Required for Binding to Elongation Factor G*

Kouji NakamuraDagger, Hideki Miyamoto, Satoru Suzuma, Taiichi Sakamoto§, Gota Kawai§, and Kunio Yamane

From the Institute of Biological Sciences, University of Tsukuba, Tsukuba-shi, Ibaraki 305-8572, Japan and the § Department of Industrial Chemistry, Chiba Institute of Technology, 2-17-1 Tsudanuma, Narashino-shi, Chiba 275-0016, Japan

Received for publication, February 13, 2001, and in revised form, April 5, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Escherichia coli cells contain abundant amounts of metabolically stable 4.5 S RNA. Consisting of 114 nucleotides, 4.5 S RNA is structurally homologous to mammalian 7 S RNA, and it plays an essential role in targeting proteins containing signal peptide to the secretory apparatus by forming an signal recognition-like particle with Ffh protein. It also binds independently to protein elongation factor G (EF-G) and functions in the translation process. This RNA contains a phylogenetically conserved RNA domain, the predicted secondary structure of which consists of a hairpin motif with two bulges. We examined the binding activity of mutants with systematic deletions to define the minimal functional interaction domain of 4.5 S RNA that interacts with EF-G. This domain consisted of 35-nucleotides extending from 36 to 70 nucleotides of mature 4.5 S RNA and contained two conserved bulges in which mutations of A47, A60, G61, C62, A63, and A67 diminished binding to EF-G, whereas those at A39, C40, C41, A42, G48, and G49 did not affect binding. These data suggested that the 10 nucleotides in 4.5 S RNA, which are conserved between 4.5 S RNA and 23 S rRNA, have a key role for EF-G binding. Based on the NMR-derived structure of mutant A47U, we further verified that substituting U at A47 causes striking structural changes and the loss of the symmetrical bulge. These results indicate the mechanism by which EF-G interacts with 4.5 S RNA and the importance of the bulge structure for EF-G binding.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Escherichia coli 4.5 S RNA is a structural homologue of signal recognition particle (SRP)1 7 S RNA in eukaryotic cells (1). Larsen et al. (2) proposed that the 300 nucleotides of mammalian 7 S-like RNA contain 8 helices (numbered 1 to 8). Based on the predicted secondary structure, almost all 7 S-like RNAs of eukaryotes and archaebacteria are about 300 nucleotides long and contain 8 helices. In contrast to the structural integrity of these 7 S-like RNAs, eubacterial 7 S-like RNAs differ in size and have relatively little sequence identity (29%) outside of the conserved domain. However, eubacterial 7 S-like RNAs have an identical 22-nucleotide sequence within helix 8. A phylogenetic study has revealed differences in the length and secondary structure of 7 S-like RNAs between Gram-positive and Gram-negative bacteria. Almost all Gram-negative bacteria, including E. coli and Pseudomonas aeruginosa 7 S-like RNAs are around 120 nucleotides long and can be folded into a single hairpin, corresponding to helix 8 of mammalian 7 S RNA. The 7 S-like RNAs of Gram-positive bacteria, including Bacillus subtilis (3, 4) and Clostridium perfringens (5) consist of ~270 nucleotides, and the predicted secondary stricture is strikingly similar to that eukaryotic 7 S-like RNA, although they lack helix 7. In eubacterial cells, 7 S-like RNA and Ffh protein, which is a homologue of SRP54, constitute a ribonucleoprotein particle and are involved in protein secretion (6-8). On the other hand, we showed that 4.5 S RNA can bind to the protein elongation factor, EF-G, indicating that 4.5 S RNA is also involved in translation (9, 10). Indeed, 4.5 S RNA depletion causes a significant loss of translation (11-13), and suppressors of the 4.5 S RNA requirement reside in genes encoding components of the translation system, such as EF-G, 23 S rRNA, and tRNA synthetases (14, 15). In addition, 4.5 S RNA depletion leads to an increase in the amount of EF-G associated with ribosomes, suggesting that 4.5 S RNA is concerned with the mode by which EF-G associates with ribosomes (16). Therefore, we proposed that 4.5 S RNA is a bifunctional molecule that functions in translation and protein secretion by binding each protein. Because a ternary complex consisting of 4.5 S RNA, Ffh, and EF-G was undetectable in electrophoretic mobility shift assays, the binding site for both proteins overlaps in 4.5 S RNA. Wood et al. (17) demonstrated that nucleotides within the single-stranded region in helix 8 are important both for Ffh binding to the RNA and for optimal function of the RNA in vivo. This bulged structure is phylogenetically conserved among the 7 S-like RNA family (18). In contrast to accumulating information about Ffh binding, that structural features of 4.5 S RNA that are recognized by EF-G have not been investigated. The decanucleotide sequences from 1068 to 1077 of 23 S RNA (5'-GAAGCAGCCA-3') and from 58-67 of mature 4.5 S RNA are identical (9, 15, 16). The corresponding region of 23 S RNA is considered important for one of the EF-G binding sites (19-21). However, the decanucleotide alone is not sufficient for binding EF-G, suggesting that more higher level of structure of conserved bulge is also important for protein binding (9, 16). We investigated the RNA sequence and secondary structures affecting EF-G binding as follows. We performed deletion analysis of the 4.5 S RNA sequences, systematically altered bases and secondary structures, and assessed the consequences of these changes in vitro and in vivo. An NMR structural study of a mutant 4.5 S RNA (A47U) suggested that the bulged structure is important for protein binding.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Bacterial Strains and Plasmids-- Escherichia coli strain S1192 (HfrH relA1 spoT1lacIq ffs::kan591 (lambda imm434nin5 XhoI::Phi (Ptacffs)) was a gift from S. Brown (Department of Molecular Biology, University of Copenhagen, Denmark) (14). The 5' portion of the normal chromosomal 4.5 S RNA gene in this strain has been replaced by a kanamycin-resistance determinant. The chromosome contains a second bacterial ffs gene that is expressed from the inducible Ptac promoter as a part of a recombinant vector. A vector used to prepare the 32P-labeled RNA was pSP64 (Promega, Madison, WI). Plasmid pKK223-3 (-op) is a derivative of pKK223 (Amersham Pharmacia Biotech, Uppsala, Sweden), which contains the promoter sequence of the tac promoter without the putative repressor-binding site (16). Therefore, this plasmid can allow the gene cloned under the tac promoter to constitutively express in E. coli cells. The 4.5 S RNA genes with or without mutations were synthesized by annealing two chemically synthetic oligo DNAs encoding each mutant and introducing them between the BamHI/PstI sites of pKK223-3 (-op) or between the BamHI/HindIII sites of pSP64.

In Vitro Synthesis of 32P-labeled 4.5 S RNAs with or without Mutation-- The DNA templates for in vitro transcription were generated by BamHI digestion of plasmid DNAs of the pSP64 series encoding wild-type or mutant 4.5 S RNA. The transcription reaction contained 40 mM Tris-HCl (pH 7.9), 6 mM MgCl2, 10 mM dithiothreitol, 2 mM spermidine, 50 µg/µl bovine serum albumin, 10 mM NaCl, 0.5 mM each of ATP, UTP, GTP, 25 µM CTP, 70 units of RNase inhibitor (Takara Shuzo Co., Ltd., Kyoto, Japan), 10 µl of [alpha -32P]CTP (400 Ci/mmol, Amersham Pharmacia Biotech, International, Little Chalfont, Buckinghamshire, UK), 1 pmol of linearized DNA fragment, and 35 units of SP6 RNA polymerase (Takara Shuzo). After reaction, RNA was precipitated with ethanol twice. Purified RNAs were resolved in sterile and deionized water. The concentrations of radiolabeled RNAs were determined from the specific activity of [alpha -32P]CTP incorporation into the transcripts. Prior to use, RNAs were renatured by incubation for 15 min at 65 °C followed by slow cooling to room temperature.

Production and Purification of Recombinant EF-G with a Tag Consisting of Six Consecutive Histidine Residues at the Carboxyl Terminus-- E. coli EF-G mutant (EF-GDelta -(1-91)), with a deletion of all upstream sequence up to and including the second GTP-binding sequence element, was expressed and purified as described by Suzuma et al. (10). To express EF-GDelta (1-91), E. coli M15 harboring both pREP4 (Qiagen, Chatsworth, CA), and the plasmid encoding mutant EF-G was cultured on LB plates in the presence of 50 µg/ml of ampicillin. A single colony was inoculated into 20 ml of 2XTY medium containing 100 µg/ml ampicillin and 10 µg/ml kanamycin and then incubated for 16 h at 37 °C. A 10-ml inoculum of the overnight cultures was added to 1 liter of 2XTY medium containing 100 µg/ml ampicillin and then cultured to A600 = 0.6 at 37 °C and induced with 2 mM IPTG for 5 h at 37 °C. The cells were pelleted by centrifugation at 5,000 × g for 5 min. and resuspended in sonic buffer (50 mM sodium phosphate (pH 8.0), 300 mM NaCl) at 5 volumes/gram (wet weight). The suspension was disrupted by sonic oscillation (30-min bursts/30-min cooling/30-min bursts at 18 kc) using a Kubota Insonator Model 200 M (Kubota Medical Appliance Supply Co., Tokyo, Japan) at 4 °C. The sonicate was separated by centrifugation at 10,000 × g for 20 min at 4 °C. The precipitate was dissolved in sonication buffer containing 8 M urea and then applied to a 20-ml column of Ni2+-nitroacetate resin (NTA; Qiagen) equilibrated with the same buffer. Weakly bound proteins were removed with buffer A (10 mM Na+, HEPES (pH 7.6), 150 mM NaCl, 10% glycerol, 0.1 mM phenylmethylsulfonyl fluoride, 10× resin volume). Proteins attached to the resin were finally eluted with buffer A containing 0.2 M imidazole. Fractions containing proteins were pooled and sequentially dialyzed against buffer B (20 mM Tris-HCl (pH 7.5), 0.5 M NaCl, 50% glycerol, 2 mM dithiothreitol, 1 mM EDTA) containing 8, 4, 2, 1, 0.5, and 0.05 M urea. Purified proteins were stored at -30 °C.

Nitrocellulose Filtration Assay-- The 32P-labeled 4.5 S RNA probes (0.15 nM, 1.3 × 1018 cpm/mol) were incubated for 1 min at room temperature with various concentrations of purified EF-G (0.001-10 µM) in 10 µl of buffer (20 mM Tris-HCl (pH 7.4), 10 mM MgCl2, 50 mM NaCl, 0.3% vanadium ribonucleoside complex, and 1 unit of poly (dI-dC)). The mixture was then diluted with 0.5 ml of washing buffer containing 20 mM Tris-HCl (pH 7.4), 10 mM MgCl2, 100 mM NaCl, and 10% glycerol and immediately passed through nitrocellulose filters (Advantec, 0.45-nm pore size; Toyo Roshi Kaisha, Tokyo, Japan), which were washed with 1.5 ml of washing buffer. The levels of radioactivity remaining on the filters were determined using a liquid scintillation counter (LS5000TA , Beckman).

RNA Synthesis and Purification for NMR Study-- The 49-nucleotide fragment corresponding to the region from 29 to 77 of wild-type 4.5 S RNA (SRP49) was made by annealing two synthetic oligonucleotides. The oligonucleotides were designed to attach the T7 phage promoter sequence at the 5' end of RNA coding region. The 49-nucleotide DNA fragment encoding a mutant 4.5 S RNA where A at position 47 of wild-type 4.5 S RNA is replaced by U was also constructed (A47U). The SRP49 and the mutant (A47U) were synthesized using an Ampliscribe T7 High Yield Transcription Kit (Epicentre Technologies Corporation). We prepared 15N-labeled RNA using 15N-NTPs (99.0 atom %, Nippon Sanso, Japan). After transcription, RNAs were purified by 15% polyacrylamide gel electrophoresis under denaturing conditions with 7 M urea. The RNAs were eluted from gel in 0.3 M sodium acetate, precipitated with ethanol, and desalted by ultrafiltration using Centricon-3 (exclusion molecular weight 3,000) (Amicon).

NMR Experiments-- The purified RNAs were incubated for 5 min at 95 °C and then cooled on ice. Samples containing 0.2-0.6 mM RNA were dissolved in 200 µl of 10 mM sodium phosphate buffer (pH 6.3) in 90% H2O, 10% D2O, and NMR spectra were measured using a DRX-500 spectrometer (Bruker) at probe temperatures of 10-50 °C with symmetrical NMR microtubes (Shigemi Co., Ltd., Tokyo, Japan). Solvent signals were suppressed by the jump-and-return pulse (22) for all experiments with pulse intervals of 65 µs. For one-dimensional measurements, the spectral width was 25 ppm, data points of 32 K were used, and the number of scans was 128. Prior to Fourier transformation, line broadening of 3 Hz was applied. Two-dimensional NOESY experiments (23) were acquired with a mixing time of 150 ms. 512 free induction decays of 2 K data points were collected using the States-TPPI (time proportional phase incrementation) methods (23); the number of scans was 256. Prior to Fourier transformation, pi /2-shifted squared sine bell function for the t2 dimension and pi /2-shifted sine bell function for the t1 dimension were applied, and zero-filling was applied to acquire real 2K 1K spectra. For two-dimensional 15N-1H HMQC experiments, the interpulse delay was 4 ms, and 15N was decoupled according to the GARP (global optimized alternating-phase rectangular pulses) scheme (24) with a 90 °C pulse of 150 µs. Free induction decays (16 scans each) of 4 K data points in the t2 domain were collected for 64 data points in the t1 domain in the phase-sensitive mode using the States-TPPI method (23). The spectra of 2K × 256 data points were obtained by zero filling the t1 domain and the pi /2-shifted sine bell function for both the t1 and t2 dimensions followed by Fourier transformation. The spectral width for 15N was 100 ppm.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Binding Activity of 4.5 S RNA to EF-G-- E. coli 4.5 S RNA can bind both Ffh and EF-G. We examined the dose dependence of Ffh and EF-G Delta -(1-91) binding upon full size 4.5 S RNA using a filter binding assay as described by Suzuma et al. (10). The binding affinity values (M1/2) for Ffh and EF-G, defined as the concentration that gave half-maximal binding, were 0.15 and 1.5 µM, respectively, indicating that the affinity of EF-G for 4.5 S RNA was lower than that of Ffh by approximately one order of magnitude.

Effects of Point Mutations in Conserved Bulge Structures on Protein Binding-- Fig. 1 shows that E. coli 4.5 S RNA can be folded into a single hairpin. This structure is considered homologous to domain IV of mammalian SRP RNA (7 SL RNA). In addition to the secondary structure, several nucleotides are highly conserved. These lie with the tetranucleotide loop and its adjacent single-stranded bulged regions. No other regions are universally conserved in the primary sequence of 7 SL-like RNAs. Moreover, among bacterial SRP RNAs, the numbers and structures of single-stranded bulges are conserved (25). A mutational study demonstrated that nucleotides within the bulge regions are important for Ffh binding to the RNA (26, 27). To determine the role of the bulge(s) and to identify which nucleotides are essential for EF-G binding, we performed site-directed mutagenesis studies on each bulge region. The ability of EF-G to bind the mutant 4.5 S RNAs was examined using a nitrocellulose filtration assay (Fig. 2). Within bulge A, point mutations at positions 47, 60, 61, 62, and 63 completely abolished binding, whereas those at G48U and G49C did not. A mutation from A to U at position 67, which lies within bulge B, also completely abolished the ability to bind EF-G, whereas point mutations within the opposed bulged residues at positions 39, 40, 41, and 42 did not. In contrast, all point mutations induced within bulges C, D, and E did not affect binding to EF-G. These results suggest that the nucleotide region that includes bulges A and B is necessary for EF-G binding.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   Predicted secondary structure and nucleotide sequence of E. coli 4.5 S RNA. The numbering corresponds to full-length E. coli 4.5 S RNA. Internal bulges are lettered A to E. A thick line marks the decanucleotide sequence identical in 4.5 S and 23 S RNAs.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 2.   Protein binding activities of wild-type 4.5 S RNA and site-directed mutants at bulges A-E. Nucleotide replaced derivatives of 4.5 S RNA were filter-assayed as described under "Materials and Methods," and radioactivity retained on filters was plotted against the concentration of added EF-G.

Systematic Deletion of 4.5 S RNA to Produce the Minimal Binding Site for EF-G-- As a prerequisite to structural studies of the RNA required for protein binding, a minimal RNA site for specific protein binding had to be developed. This was accomplished by the systematic deletion of entire bulges or portions of helices from wild-type 4.5 S RNA. Genes encoding deletions were constructed by annealing two complementary single-stranded DNAs. Each deletion mutant contained a complementary sequence at the 5' and 3' termini (5'-GGGGG-3' and CCCCCACCC-3') to minimize the potential for alternative secondary structure formation as a result of deletion (Fig. 3A). Mutants 1 and 2, in which bulges E or both D and E were deleted, bound to EF-G with wild-type affinity (Fig. 3B). Another mutant with three deleted bulges (C, D, and E) also bound to EF-G with wild-type affinity. Mutant 3 consisted of bulges A and B in addition to the conserved domain IV, demonstrating that the structure of mutant 3 contains all the elements required for interaction with EF-G. To assess the importance of bulges A and B, we constructed mutants 4 and 5 that contained either bulge A or B in addition to the stem-loop structure. Fig. 3B shows that bulge A by itself has and can maintain appreciable binding affinity, whereas mutant 5 completely loss the activity. These results indicate that bulge A constitutes a minimal site in 4.5 S RNA required for binding to EF-G.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Protein binding activity of wild-type 4.5 S RNA and deletion mutants. A, sequences and possible secondary structures of E. coli 4.5 S RNA and deletion mutants. Predicted secondary structures of mutants were generated based on that of wild-type 4.5 S RNA. The numbering corresponds to full-length E. coli 4.5 S RNA. Internal bulges are lettered A-E. Boxed sequences of 5 and 10 nucleotides were added at both the 5' and 3' termini, respectively, to stabilize the terminal stem structure. B, RNA retention curves from filter binding assay. Binding activities of wild-type and mutant 4.5 S RNA were monitored by filter assays as described under "Materials and Methods." Radioactivity retained on the filter was plotted against the concentration of EF-G added.

Function of the Deletion Mutant of 4.5 S RNA in Vivo-- To examine the ability of the constructed deletion mutants shown in Fig. 3 to restore the growth of E. coli S1192 in the absence of IPTG, wild-type and deletion mutant 4.5 S RNA genes were inserted into plasmid pKK223-3 (-op) and introduced into S1192. The introduced genes were under the control of the tac promoter with a deleted operator sequence in all constructs. Therefore, the expression of 4.5 S RNA on the plasmid was independent of IPTG. The single copy of the 4.5 S RNA gene in the chromosome of S1192 is regulated by the lac repressor and requires IPTG for growth except when harboring a plasmid that provides 4.5 S RNA function. Therefore, growth in the absence of IPTG would be a good indicator of mutant function. The growth was maintained by a strain harboring wild-type 4.5 S RNA (Fig. 4) but was abolished by a plasmid without an insert in the absence of IPTG (data not shown), indicating that the phenotype of plasmid-borne 4.5 S RNA can be assessed using this in vivo system. The growth of transformants expressing mutants 1 and 2 was identical to that of wild-type 4.5 S RNA (Fig. 4). In contrast, mutants 4 and 5 no longer supported the growth of S1192 (Fig. 4). Mutant 3, which has decreased binding activity to EF-G, can restore the growth of S1192 but to a level of only half that of wild-type 4.5 S RNA. These results indicate a close relationship between the protein binding and growth restoration activity of 4.5 S RNA-depleted cells.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Growth restoration of E. coli 4.5 S RNA conditional mutants S1192 by introducing 4.5 S RNA derivatives. The growth of S1192-harboring plasmid pKK223-3 (-op) expressing wild type (WT) () and mutants 1 (black-triangle), 2 (black-down-triangle ), 3 (black-square),4 (), and 5 (black-diamond ) was monitored by measuring absorbance at 660 nm.

Comparison of NMR Spectra of SRP49 and A47U Mutant-- Fig. 5a shows two-dimensional 15N-1H HMQC spectra (imino proton region) of the SRP49 (black) and A47U (red) at 25 °C. The imino proton resonances of G and U were distinguished by their corresponding 15N chemical shifts. The resonances were assigned by analyzing two-dimensional NOESY spectra as follows (data not shown). The imino proton resonances of three SRP49 G:U pairs U36:G70, U37:G39, and U45:G64 were identified by their unique chemical shifts and strong intra-base pair NOEs. The imino proton resonance of G53 in the GGAA tetraloop was also identified by its unique chemical shift (25, 28). Starting from these unique resonances, resonances were sequentially assigned by NOE connectivity as U36/G70-G5-G4-G3-G2-G1, U45/G64-G44, and G53-G57-G58. The assignments of imino protons of SRP49 in this study were consistent with earlier NMR findings of SRP RNA (25, 28, 29). The imino proton resonances of U37, U38, G43, G49, U50, G54, G61, and G69 could not be observed or assigned because of broadening of the resonances, suggesting that these imino protons are not involved in hydrogen bonding. These results are summarized as the secondary structure shown in Fig. 5b. The spectra of SRP49 and A47U are almost identical except for three resonances (13.54, 13.25, and 13.02 ppm, Fig. 5a, red triangle) and the disappearance of the two resonances (11.85 and 11.34 ppm, Fig. 5a, black triangle). From the analysis of two-dimensional NOESY spectra, most of the imino proton resonances were assigned as described above (data not shown). The two missing resonances were assigned to a U45:G64 pair, because this pair is closest to the substituted residue (A47U) among the observed G:U pairs. This assignment was consistent with the fact that the resonances at 11.90 and 11.43 ppm were assigned to the U36:G70 pair based on the NOE connectivity of U36/G70-G5-G4-G3-G2-G1. Although the new resonances could not be assigned sequentially because of the lack of NOEs, the resonance at 13.54 ppm was identified as an A:U pair because of the presence of a typical NOE between the imino proton of U and the H2 proton of A (data not shown). Because the U45:G64 pair disintegrated and a new A:U pair formed in the A47U mutant, we proposed the secondary structure shown in Fig. 5c, in which U45 bulges outward. The proposed secondary structure is similar to that of SRP49 except for the proposed EF-G binding region, which is consistent with the fact the spectra of SRP49 and the A47U mutant were almost identical except for five resonances. Accordingly, we suggest that the conformation around U47 in the A47U mutant differed from that of the corresponding region in SRP49 and that other regions were similar between the A47U mutant and SRP49. Thus, the loss of EF-G binding activity in A47U may result from destruction of the active conformation around A47.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5.   NMR Spectra of SRP49 and A47U mutant. Two-dimensional 15N-1H HMQC spectra of SRP49 (black) and A47U (red) measured on 500 MHz NMR spectrometer in sodium phosphate buffer (pH 6.3) containing 5% D2O at 25 °C (a). Imino proton resonance assignments are denoted by residue numbers. The new resonances and the missing resonances are denoted by red and black triangles, respectively. The secondary structure of SRP49 (b) and proposed secondary structure of A47U mutant (c). The A47 and U47 residues are indicated in red.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Our previous study suggested that 4.5 S RNA is dual function and participates in both translation and secretion by interacting with EF-G and Ffh, respectively (9, 16). Here we examined the region required for EF-G binding by introducing substitutions and deletions with the 4.5 S RNA coding region of the ffs gene. The effects of sequence elements and the secondary structure of phylogenetically conserved bulged regions were measured by mutagenic alteration of 4.5 S RNA. Changing any of the bulges C, D, or E did not significantly affect the binding activity. Moreover, even in bulge A or B, changes in nucleotide positions 39, 40, 41, 42, 48, and 49 did not reveal a key role in EF-G protein binding. In contrast, nucleotides 60, 61, 62, 63, and 64 in the conserved decanucleotide sequence were important for efficient binding because some mutations at this site almost completely abolished the binding. This result is consistent with our data showing that wild-type 4.5 S RNA can compete with 23 S RNA for binding to EF-G, but mutants with base substitutions in the decanucleotides cannot (9, 16). On the other hand, Wood et al. (17) demonstrated that point mutations within the bulged residues at positions 47, 48, 49, 61, and 62 completely abolish binding to Ffh, whereas mutations at positions 60 and 63 do not affect the binding. Taken together, these data suggest that nucleotides within single-stranded regions in bulges A and B are important for binding to both proteins and that the nucleotides essential for binding to each protein are overlapping but not identical. Our present data using deletion mutants indicated that mutant 2, consisting of 49 nucleotides (SRP49), is sufficient for protein binding and can restore the growth of 4.5 S RNA conditional mutant in the absence of IPTG. This 4.5 S RNA is the shortest among known SRP 7 S-like RNAs. Defining regions for EF-G binding would be useful in generating a minimal structure that would allow structural analysis by NMR. The structures of 24-, 28-, and 43-nucleotide fragments of 4.5 S RNA have been studied using multidimensional NMR (25, 29, 30). The crystal structure of the complex between the RNA-binding domain of Ffh (M domain) and the fragment of 4.5 S RNA has recently been determined at a resolution of 1.8 Å (31). This result demonstrates that in the symmetric loop (bulge A), stacking of five consecutive non-canonical base pairs generates a unique helical structure with a shallow minor groove. This groove in the symmetrical internal loop A (bulge A, in this study) is recognized by the alpha -helix-turn-helix (HTH) motif contained within the five alpha -helices of the Ffh M domain. Moreover, this groove was occupied by the hydrophobic segment of a neighboring M domain. In vitro chemical protection of 4.5 S RNA by Ffh showed that the protein mainly protects the 5' side of domain IV, with highly conserved nucleotides A39, A47, G48, and G49 being the most protected (27). The nucleotides that are essential for EF-G binding were located opposite those important for Ffh binding, from the 3' side of bulge A. The EF-G binding sites within 4.5 S and 23 S rRNA contain the same decanucleotide sequence. This decamer RNA sequence is included in the recent reported structure of ribosomal protein L11 in complex with a fragment of 23 S rRNA (32, 33). Comparison of the EF-G binding sites in 4.5 S RNA and 23 S rRNA shows that the last five decanucleotide residues have almost identical conformations (31, 34). In contrast, the first decanucleotide residues have a distinct orientation, showing a common structural feature likely to be important for the recognition of both RNAs by EF-G. To compare the tertiary structure of the proposed protein binding site, we constructed a model structure of the A47U mutant in which bulge A forms an A-type helical structure (Fig. 6), because substitution of A47 with U caused a loss of binding activity to both Ffh and EF-G. Therefore, remarkable conformational changes must occur in the binding region of the A47U mutant. Fig. 6 shows that at least three standard base pairs are stretched. Moreover, the amino groups of C46 and C62 were involved in base pairing, and the protruding phosphate backbone that may interact with proteins as a hydrogen bond acceptor in SRP RNA is different between the SRP49 and A47U mutant models. Thus, single changes can cause large conformational changes that may have brought about the loss of Ffh and EF-G binding affinity in the A47U mutant. Replacement of A47 with cytosine did not affect the binding activity (data not shown), suggesting that A47 is important for maintaining non-canonical helices rather than because it is recognized by proteins.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   Comparison of three-dimensional structural models of the proposed EF-G binding region. The EF-G binding region of the A47U mutant (a) and three-dimensional structure of the corresponding region of SRP49 reproduced from Ref. 29 (b). The strand containing G44-G48 is blue, C62-C65 is yellow, and A47 and U47 are red. The model was constructed on an Octane work station (Silicon Graphics) with the program Insight II (Biosym molecular simulation). U45, which is believed to bulge outward, is not shown in the model.

Here, we have defined the minimal structure of 4.5 S RNA for binding EF-G. Taken together with previous data reported by Wood et al. (17), these data suggest that Ffh and EF-G proteins recognize overlapping domains in the 4.5 S RNA. As mentioned above, an identical decanucleotide sequence is found in the EF-G binding sites of both 4.5 S and 23 S rRNA. Jovine et al. (34) indicated that the last five decanucleotide residues have almost identical conformations (root mean square deviation = 0.96 Å). With this structure resemblance, 4.5 S RNA can acquire the ability to compete with 23 S rRNA. Moreover, it is plausible that these sequences in both 4.5 S and 23 S rRNA act as the first binding site for EF-G. The biological function of the interaction between 4.5 S RNA and EF-G during translation remains to be determined. On the basis of all previous data including the structural comparison, we proposed that 4.5 S RNA might facilitate EF-G-GDP to be expelled from the ribosome by competing with 23 S rRNA for EF-G binding (9, 16). However depletion of 4.5 S RNA leads to the rapid inhibition of translation, and this loss of translation by depletion of 4.5 S RNA extends to the whole protein (13). Under normal conditions 4.5 S RNA is not a stable component of the ribosome, but once cells are treated with fusidic acid or viomycin, 4.5 S RNA comigrates with 70 S ribosome in a sucrose gradient. Under these conditions, distribution of Ffh protein was unchanged. Moreover, our quantitative analysis demonstrated that almost all Ffh protein in a cell makes a stable complex, and the amounts of this complex are unchanged through cell growth (10). Thus, the function of 4.5 S RNA in translation may be separable from that in protein secretion. Therefore, even if EF-G and Ffh can compete for 4.5 S RNA binding, this might not contribute to the function of 4.5 S RNA in translation.

    ACKNOWLEDGEMENTS

We thank N. Foster for critical reading of the manuscript.

    FOOTNOTES

* This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science and Sports, and Culture of Japan, by Mitsubishi Chemical Corporation Fund, and in part by the "Research for the Future" program (JSPS-RFTF97L00503) from the Japan Society for the Promotion of Science.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel. and Fax: +81-298-53-6006; E-mail: nakamura.kouji@nifty.ne.jp.

Published, JBC Papers in Press, April 9, 2001, DOI 10.1074/jbc.M101376200

    ABBREVIATIONS

The abbreviations used are: SRP, signal recognition particle; bp, base pair(s); EF-G, elongation factor G; HMQC, heteronuclear multiquantum coherence; IPTG, isopropyl-beta -D-thiogalactopyranoside; NOE, nuclear Overhauser effect; NOESY, NOE spectroscopy.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Poritz, M. A., Strub, K., and Walter, P. (1988) Cell 55, 4-6[Medline] [Order article via Infotrieve]
2. Larsen, N., Samuelsson, T., and Zwieb, C. (1998) Nucleic Acids Res. 26, 177-178[Abstract/Free Full Text]
3. Struck, J. C. R., Vogel, D., Ulbrich, N., and Erdmann, V. A. (1988) Nucleic Acids Res. 16, 2720[Medline] [Order article via Infotrieve]
4. Nakamura, K., Imai, Y., Nakamura, A., and Yamane, K. (1992) J. Bacteriol. 174, 2185-2192[Abstract]
5. Nakamura, K., Hashizume, E., Shibata, T., Nakamura, Y., Mälä, S., and Yamane, K. (1995) Microbiology 141, 2965-2975[Abstract]
6. Lütcke, H. (1995) Eur. J. Biochem. 228, 531-550[Abstract]
7. Ribes, V., Römisch, K., Giner, A., Dobberstein, B., and Tollervey, D. (1990) Cell 63, 591-600[Medline] [Order article via Infotrieve]
8. Luirink, J., High, S., Wood, H., Giner, A., Tollervey, D., and Dobberstein, B. (1992) Nature 359, 741-743[CrossRef][Medline] [Order article via Infotrieve]
9. Shibata, T., Fujii, Y., Nakamura, Y., Nakamura, K., and Yamane, K. (1996) J. Biol. Chem. 271, 13162-13168[Abstract/Free Full Text]
10. Suzuma, S., Hayashi, K., Nakamura, K., and Yamane, K. (1999) FEMS Microbiol. Lett. 180, 271-277[CrossRef][Medline] [Order article via Infotrieve]
11. Brown, S., and Fournier, M. J. (1984) J. Mol. Biol. 178, 533-550[Medline] [Order article via Infotrieve]
12. Bourgaize, D. B., Phillips, T. A., VanBogelen, R. A., Jones, P. G., Neidhardt, F. C., and Fournier, M. A. (1990) J. Bacteriol. 172, 1151-1154[Medline] [Order article via Infotrieve]
13. Bourgaize, D. B., and Fournier, M. A. (1987) Nature 325, 281-284[CrossRef][Medline] [Order article via Infotrieve]
14. Brown, S. (1987) Cell 49, 825-833[Medline] [Order article via Infotrieve]
15. Brown, S. (1989) J. Mol. Biol. 209, 79-90[Medline] [Order article via Infotrieve]
16. Nakamura, K., Fujii, Y., Shibata, T., and Yamane, K. (1999) Eur. J. Biochem. 259, 543-550[Abstract/Free Full Text]
17. Wood, H., Luirink, J., and Tollervey, D. (1992) Nucleic Acids Res. 20, 5919-5925[Abstract]
18. Selinger, D., Brennwald, P., Liao, X., and Wise, J. A. (1993) Mol. Cell. Biol. 13, 1353-1362[Abstract]
19. Sköld, S. E. (1983) Nucleic Acids Res. 11, 4923-4932[Abstract]
20. Moazed, D., Robertson, J. M., and Noller, H. F. (1988) Nature 334, 362-364[CrossRef][Medline] [Order article via Infotrieve]
21. Liljas, A., and Garber, M. (1995) Curr. Opin. Struct. Biol. 5, 721-727[CrossRef][Medline] [Order article via Infotrieve]
22. Plateau, P., and Gueron, M. (1982) J. Am. Chem. Soc. 104, 7310-7311
23. Ernst, R. R., Bodenhausen, G., and Wokaun, A. (1987) in Principles of Nuclear Magnetic Resonance on One and Two Dimensions (Breslow, R. , Goodenough, J. B. , Halpern, J. F. , and Rowlinson, J. S. F., eds) , pp. 516-527, Oxford Science Publications, Oxford
24. Shaka, A. J., Baker, P. B., and Freeman, R. (1985) J. Magn. Reson. 64, 547-552
25. Schmitz, U., Freymann, D. M., James, T. L., Keenan, R. J., Vinayak, R., and Walter, P. (1996) RNA 2, 1213-1227[Abstract]
26. Gowda, K., and Zwieb, C. (1997) Nucleic Acids Res. 25, 2835-2840[Abstract/Free Full Text]
27. Lentzen, G., Moine, H., Ehresmann, C., Ehresmann, B., and Wintermeyer, W. (1996) RNA 2, 244-253[Abstract]
28. Heus, H. A., and Pardi, A. (1991) Science 253, 191-194[Medline] [Order article via Infotrieve]
29. Schmitz, U., Behrens, S., Freymann, D. M., Keenan, R. J., Lukavsky, P., Walter, P., and James, T. L. (1995) RNA 5, 1419-1429[Abstract/Free Full Text]
30. Schmitz, U., James, T. L., Lukavsky, P., and Walter, P. (1999) Nat. Struct. Biol. 6, 634-638[CrossRef][Medline] [Order article via Infotrieve]
31. Batey, R. T., Rambo, R. P., Lucast, L., Rha, B., and Doudna, J. A. (2000) Science 287, 1232-1239[Abstract/Free Full Text]
32. Wimberly, B. T., Guymon, R., McCutcheon, J. P., White, S. W., and Ramakrishman, V. (1999) Cell 97, 491-502[Medline] [Order article via Infotrieve]
33. Conn, G. L., Draper, D. E., Lattman, E. E., and Gittis, A. G. (1999) Science 284, 1171-1174[Abstract/Free Full Text]
34. Jovine, L., Hainzl, T., Oubridge, C., Scott, W. G., Sizma, T. K., Wonacott, A., Skarzynski, T., and Nagai, K. (2000) Struct. Fold. Des. 8, 527-540[Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.